Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

183C91

 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Oxazoles

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Bioequivalence and Rapid Absorption of Zolmitriptan Nasal Spray Compared with Oral Tablets in Healthy Japanese Subjects
AbstractBackground and objective: Oral zolmitriptan is highly effective in the acute treatment of migraine. However, nausea and… Expand
2002
2002
Pharmacokinetics, Dose Proportionality, and Tolerability of Single and Repeat Doses of a Nasal Spray Formulation of Zolmitriptan in Healthy Volunteers
The objective of this study was to investigate the pharmacokinetics, dose proportionality, and tolerability of a range of single… Expand
2002
2002
The pharmacokinetics of the antimigraine compound zolmitriptan in Japanese and Caucasian subjects
HeadingAbstract Background. Zolmitriptan is a 5HT1B/1D receptor agonist effective in the acute treatment of migraine. Clinical… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
2002
2002
Evaluation of the Effect of Xylometazoline on the Absorption of Zolmitriptan Nasal Spray
Zolmitriptan is a serotonin 5-HT1B/1D receptor agonist that is highly effective for the acute treatment ofmigraine.[1] Following… Expand
2002
2002
Preliminary Studies of the Pharmacokinetics and Tolerability of Zolmitriptan Nasal Spray in Healthy Volunteers
Two preliminary studies of the pharmacokinetics and tolerability of zolmitriptan nasal spray were conducted, each involving 12… Expand
Highly Cited
1999
Highly Cited
1999
Characterisation of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques.
5-Hydroxytryptamine (5-HT) can produce both vasoconstrictor and vasorelaxant effects in human coronary arteries and the response… Expand
1998
1998
The absolute bioavailability and effect of food on the pharmacokinetics of zolmitriptan in healthy volunteers.
AIMS Zolmitriptan (Zomig (formerly 311C90)) is a novel 5-HT1B/1D receptor agonist developed for the acute oral treatment of… Expand
  • table 2
  • table 1
1998
1998
The Metabolism of Zolmitriptan
SummaryTwo studies were conducted in healthy volunteers to evaluate the effects of rifampicin and cimetidine on the… Expand
Review
1997
Review
1997
Potential drug interactions with the novel antimigraine compound zolmitriptan (Zomig™, 311C90)
  • P. Rolan
  • Cephalalgia : an international journal of…
  • 1997
    • Corpus ID: 30479192
Seven randomized studies in healthy volunteers have investigated interactions between zolmitriptan (Zomig™, formerly 311C90), a… Expand
  • figure 1
  • table 2
1997
1997
The novel anti-migraine compound zolmitriptan (Zomig 311C90) has no clinically significant interactions with paracetamol or metoclopramide
AbstractObjective: This study investigated potential pharmacokinetic or pharmacodynamic interactions between the novel anti… Expand
  • figure 1
  • table 1
  • figure 3
  • figure 2
  • table 2
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE